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Abstract
Cost effective disease control on the dairy farm can enhance productivity and
subsequently profitability.  Previous economic studies on animal disease have focused on
production losses and evaluation of disease eradication programs and provided little
guidance as to the optimal prevention action.  This paper presents a theoretical model on
the economics of livestock disease and develops an empirical model to determine the
optimal set of control strategies for four production limiting cattle diseases: bovine viral
diarrhea (BVD), enzootic bovine leukosis (EBL), Johne’s Disease (JD) and neosporosis.
Control functions indicating the prevalence of infection with each of the four diseases for
each of the ten strategies are estimated.  The optimal strategies that minimize total
disease cost (direct production losses and control expenditures) are provided for each
disease on the basis of farm survey results from the Maritime provinces.  The results
emphasize the importance of introduction checks before new animals enter the herd and
adequate vaccination protection as cost-effective control strategies.3
THE ECONOMICS OF CONTROLLING INFECTIOUS DISEASES ON DAIRY
FARMS
Net returns to producers and processors in the dairy sector are negatively affected
by disease.  Disease can reduce the efficiency of inputs which are converted to outputs
(i.e. lower feed efficiency or increasing cow mortality) thereby lowering profit margins
through higher input costs and/or lower yields.  Diseases can also reduce revenue through
lower quality and lower production levels.  Consumer reaction to the prevalence of
disease could also cause a shift in the demand curve leading to a drop in output price.
This aggregate effect may reduce the competitive position of a given sector relative to
other sectors within the region or relative to the same sector across regions.
In the Canadian dairy sector, there is concern regarding the effects of four
production limiting diseases: bovine viral diarrhea (BVD), enzootic bovine leukosis
(EBL), Johne’s Disease (JD) and neosporosis.  The concern has been manifested in the
formation of the Production Limiting Disease Committee (PLDC) in 1997.  The four
dairy diseases that are the focus of the PLDC are not treatable and presumed to impose
large productivity losses on affected farms although the actual extent of the costs is
unknown.  The losses are mainly from reduced milk production due to mortality, weight
loss, abortion, and growth retardation.  These diseases may also become a focus of public
health attention as is the case with JD and its possible connections with Crohn’s disease
in people (Fidler et al. 1994).  At the present time, detection and removal of permanently
infected cattle from herds are considered as the primary ways of preventing the diseases.
Little is known about the actual costs and benefits of the possible methods for controlling
any of the four dairy diseases.4
The few studies examining the economics of animal disease have tended to focus
exclusively on the losses to producers (Bennett 1992) or on the value of eradication
programs (Dijkhuizen et al. 1995).  Losses are estimated as the proportion of animals
with the disease multiplied by the number of animals in the region and by the dollar value
per animal of lost output as compared to a healthy animal.  A major limitation in defining
the optimality of resource use is that this approach fails to recognize prevention and
treatment costs.  Total losses from the disease should include not only direct production
losses but also control expenditures.  In addition, knowing the dollar value of yield losses
only indicates the existence of a problem but no direction on how to deal with it.
Assessing the relationship between control strategies and disease prevalence allows for
the calculation of the total losses from the disease associated with alternative control
practices.  The optimal management strategy minimizes total disease costs.
The purpose of this paper is to determine the optimal set of control practices that
minimize the total economic costs for each of the following four production limiting
diseases: BVD, EBL, JD and neosporosis.  The paper begins with the development of a
conceptual model assessing the optimal level of control practices and it considers both
direct losses and control expenditures.  Within this first section, the fallacy of examining
only direct disease losses when addressing how to manage a given disease is discussed.
The second section of the paper develops an empirical model of the study conducted for
the Maritime provinces.  The prevalence of the disease infection for each of the ten
control strategies is predicted and then fed into a spreadsheet model to measure the ex
post costs at the herd level from direct production losses and treatment costs.  The
optimal strategies for each of the four diseases are determined by summing the ex ante5
costs of alternative control strategies and the ex post losses, and comparing across
practices.  The paper concludes with implications of the results for herd health managers.
CONCEPTUAL MODEL
Modelling Direct Costs of Disease
The direct effects of infectious disease that have been the exclusive focus of many
previous studies can be represented by the following production function:
where Q is the flow of output (i.e. milk, weight gain), R is the level of variable inputs (i.e.
feed, labour),  N  is the size of the herd, and K is the level of fixed factors.  The disease
can lower output by increasing the mortality rate (reducing  N ) or by reducing the
efficiency of the inputs R.  The latter effect is captured by a variation of equation (1) that
assumes the disease is present  ) K   , N / R ( f
D .  Examples of a ‘healthy’ and a ‘diseased’
production function are illustrated in Figure 1 adapted from McInerney (1996).  In
addition, an input price (PR) to output price (PQ) ratio line is included.  The tangency of
this line to the production function indicates the level of variable input use that will
maximize profits (i.e. where marginal value product is equal to the marginal factor cost of
the input).
Several points to be considered when estimating the direct costs of infectious
disease of dairy cattle are shown in Figure 1.  First, the impacts will vary by farm
depending on characteristics such as size, type, or location.  For example, assuming input
use remains constant, the reduction in output for an intensive operation using an input
level of  H R  is 
D
H H Q Q − .  This loss is greater than that suffered by a low input farm
(1)                                                                      ) K , N / R ( f Q =6
(
D
L L Q Q − ) using  L R  inputs ( L R< H R ).  Second, input use will be affected so economic
costs should account for resource adjustments and not only the reduction in output.  The
original profit maximizing equilibrium without the disease is at E and the farmer uses  H R
to produce  H Q .  The disease alters the production function and the new equilibrium is
D E  with the farmer using  L R  inputs and generating an output of 
D
L Q .  The traditional
approach of determining the cost of the the disease would estimate the loss as the
reduction in output valued at output price  Q
D
L L P Q Q ⋅ − ) ( .  However, this approach
overstates the true loss because it does not account for the adjustment in input use.  The
actual loss is the difference in profit  ) ( ) ( L R
D
L Q H R H Q R P Q P R P Q P ⋅ − ⋅ − ⋅ − ⋅  or  B A−  in
Figure 1.  Note that the disease may also lead to a drop in the price of the output which
would increase the price ratio  ) / ( Q R P P  and thus lower input use and increase the extent
of the loss from the disease.
Figure 1
Modelling Disease Control
The next step to addressing optimal resource use in dealing with infectious
disease in dairy cattle is to include control expenditures in addition to the direct losses
examined in the previous section.  Disease control efforts, denoted by V, could include
both prevention and treatment costs at the farm level and institutional efforts at the
aggregate regional level.  The optimal level of disease control (and subsequently disease
level) cannot be determined using the same framework as most resources in which
additional inputs generally lead to higher output levels.  Instead, disease control is
considered a damage control input because it acts to prevent output from falling rather7
than to enhance production further.  The following framework for modelling disease
control is adapted from Lichtenberg and Zilberman (1986) who were the first to correctly
specify the indirect effects damage control inputs have on output.  Their work into
pesticides has been extended and applied by several studies including Pannell (1990) and
Fox and Weersink (1995) but this is the first attempt to extend the approach to disease
control of dairy cattle.
We begin by assuming there are two types of disease control expenditures: a)
prevention which is an ex ante response denoted by  P V ; and b) treatment which is an ex
post response to disease denoted by  T V .  The level of the disease is given by D with  O D
indicating the present level after ex ante control ( P V ).  The disease level encompasses
both the severity of a given disease and the prevalence of infection, although both
elements could be decomposed.  The present level of disease is assumed to depend on the
level of preventive care ( P V ) and other farm inputs (R) according to;
                                  (2)                                                                R)    , V ( D   D P O =
with  D inversely related to  P V   ) 0 V / D ( P < ∂ ∂ .  The function is assumed to be convex
with increasing levels of preventive care required to reduce disease levels a given amount
) 0 V / D (
2
P
2 > ∂ ∂ .  It is also assumed that R  and  P V  are substitutes as suggested by
McInerney (1996).
The resulting level of disease (D) after ex ante ) ( P V control is assumed to affect
production (Q) through the following damage function;
                               (3)                                                  F(D)]        -   1   )[ R ( Q     Q O =8
where  O Q  is the disease–free output level that depends on the level of conventional
inputs R and F(D) is the proportion of output lost with disease level D.  For simplicity,
the K and N used in the production relationship given by equation (1) are dropped from
this production function.  The decline in production can result from increased mortality or
abortion (among others) as discussed earlier.  F(D) is bounded between 0 and 1 with
production equal to  O Q  if D=0  ) 0 ) 0 ( ( = F and equal to 0 for high levels of the disease
) 1 ) ( ( = ∞ F .  While the slope of the damage function is negative, its shape is uncertain.
As production (Q) is affected by ex ante efforts  ) V ( P ,  treatment expenditure
) ( T V  can be influenced by present disease level, D, derived from  P V .  It can be shown as
the following control function:
                                        ) Q(D     VT α =                                                      (4)
where D is the level of current disease after prevention control and α  represents the
magnitude of treatment response to reduce disease symptoms of infected animals.  α  is
greater than or equal to zero (α ≥ 0), but not likely to be greater than 1 because treatment
cost greater than direct production loss is not rational.  If α  is high, farmers use more
treatment control than when α  is low.  The α  approaches 0 when there is no effort for
treating infected cows  ) 0 V ( T =  that are showing negligible signs of disease.
The profit maximization problem for the producer can be summarized as
          (5)                                                           F - V P V P R P Q P     T V P V R Q T P − − − = π
                 s.t   (2)                                                                             R)    , V ( D   D P O =
                        (3)                                                            F(D)]        -   1   )[ R ( Q     Q O =
                            ) Q(D     VT α =                                                                      (4)9
where π  is annual profit and F is the cost of all other inputs.  Substituting the control
function for preventive care (2) into the production function (3) results in the following
response function:
                         ) (3                                          R))]         , (V F(D   -   1   )[ R ( Q     Q
1
P O O =
Substitution of the production function given by  ) 3 (
1  into (5) results in an unconstrained
profit maximization problem.
The first order conditions for preventive control are
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Thus, for a given price ratio, the marginal product of preventive care and its level of use























Similarly, the first order condition for treatment control is










The marginal product of treatment is directly related to the extent of treatment response
to reduce disease symptoms of infected animals (α ) and the decrease in production with
the present level of the disease )) Q(D ( .
The final choice variable is other input use (R) and its optimal level is where,10
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Solving the three first order conditions simultaneously would allow the optimal




P V   and V    which upon substitution into the control
function (2) would enable one to calculate the optimal disease rate that accounts for both
the benefits of preventing output loss and the costs of treatment.  This optimal disease
level  ) D (
∗  can be expressed as  ) R , V , V ( D D T
 
P
∗ ∗ ∗ ∗ ∗ = .
Determining the optimal input choices requires knowledge of the production
function, the damage function and the control function.  Although knowledge in these
areas is improving accurate estimates of the effects of disease on output, the effectiveness
of treatment strategies on disease levels is somewhat limited.  However, the model can
still be used as a basis for assessing management choices.  Rather than solving for the
single optimum strategy, the profit levels of alternative strategies can be compared.
Assuming 
O R is the input use in the absence of disease, the profit level  ) (
O π  would be
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while profit for the use of management strategy i  ) (
i π involving the use of input 
i R and
control inputs of 
i
P V and 
i
T V would be
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The choice of inputs from the observable set that maximizes profits will also be
the one that minimizes the losses from the effects of the disease.  These losses will be the
difference between disease-free profit  ) (
O π and the profits of the given strategy i  ) (
i π or
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The above expression can be related to the isoquant concept proposed by
McInerney (1996).  The first cost is the ex post costs, direct loss  )] Q Q ( P [
i
o Q − plus
treatment cost ( T V V P
T ) and the second is the ex ante cost, prevention cost  ) V P ( P VP .
Assuming for the present time that other input use is not affected by the disease
) R R (
i O = , then the two cost components can be plotted on a single diagram.  The
corresponding level of direct loss, given the amount of control expenditure for alternative
control strategies, is shown in Figure 2.  A frontier of the technically efficient strategies is
given by the isoquant PP´.  For example, strategy M is better than strategy D because
each strategy results in the same level of ex post costs  ) P ( m  but ex ante cost is less with
M than with D) A A ( d m < .
Figure 2
However, there is a technical limit to reducing the losses that can be avoided.
Point A on the curve is considered the ‘technical optimum’ in disease control (McInerney
1996) and the ex post losses cannot be lowered past point  a P .  Any additional
expenditure beyond  a A would be irrational. At point A, total losses would be a C
) C A P ( a a a = + .12
The point where total losses {P+A = ] V P ) Q Q ( P [ T V
i
O Q T + − + ) V P ( P VP } is at a
minimum can be represented diagrammatically where a line of 45° slope is tangential to
PP'.  In Figure 2, total costs of the disease are minimized with strategy M, with ex post
losses of  m P  and ex ante costs of  m A .  Strategy M minimizes the avoidable costs of
disease and the remaining total losses of  ) C A P ( C m m m m = + are unavoidable.  It is the
avoidable costs that should be the focus of management decisions.  For example, both
strategies A and D have the same total losses of  ) A P A P (   C d d a a a + = + .  Most would
dismiss strategy D as technically inefficient and assume strategy A is optimal because it
reduces the ex post losses of the disease to the lowest possible level at  a P .  However, the
reduction in production loss and treatment cost come at the expense of higher prevention
expenditure.  It is undoubtedly true that a reduction in disease costs would be desirable,
but the reductions may have no obvious relation to the total cost.  Total costs also depend
on such technical factors as the nature of the disease, the technology of control methods,
the production systems employed, and management skills available (McInerney 1996).
Total losses are minimized with strategy M and the difference between losses at this point
) C ( m  and those with either strategy A or D  ) C ( a  represent the costs that can be avoided
through management choices  ) C C ( m a − .  Technical research may allow further
reductions in the unavoidable costs of  m C  but not decisions by the individual producer.13
EMPIRICAL MODEL
Definition of Control Strategies
The data on management practices and prevalence of infection with the four
diseases was obtained from a survey of 90 dairy herds in the Maritime provinces of
Canada (VanLeeuwen et al. 2001).  Using a stratified 2-stage random sampling, 90 herds
were chosen from all herds enrolled in a monthly milk recording program provided by the
Atlantic Dairy Dairy Improvement Corporation (ADLIC), with 30 herds being from each
of the provinces of New Brunswick, Nova Scotia, and Prince Edward Island.  Blood
samples were collected on each surveyed farm from 30 randomly selected cows.  While
on the farm, information on basic farm disease control practices was also gathered
through the completion of a questionnaire.  Investigated disease control practices fell into
two general categories: animal movement and control, and vaccination history.
On the basis of a statistical analysis to determine the extent of use and collinearity
among these practices (see authors), 10 potential control strategies were identified and
are listed in Figure 3.  Four general groups of practices were used to define the 18 control
strategies: 1) opportunity for direct contact, 2) source of purchased animals, 3)
introduction checks, and 4) vaccination.
The first set of practices delineating farms is whether a farm is closed or open.  A
farm is considered open if it purchases animals and/or allows for direct contact with cattle
from other herds.  Such direct contact likely increases the risk of disease infection
through nose-to-nose or fecal-oral contact.  If a farm was open, it could buy directly from
other producers or it could purchase from other sources such as dealers or public
auctions.  It is assumed that buying direct from other farmers would lower the risk of14
disease infection compared to other sources, because dealers and auctions handle cattle
from many farms, leading to greater contact with cattle from multiple sources, and
therefore more exposure to various infectious diseases.  According to the survey in the 90
Maritime dairy herds, 10 herds were found to raise a heifer for internal replacement
without purchasing from outside while 29 and 43 herds purchased animals from other
producers and dealers/auctions, respectively.
Farmers purchasing animals can undertake several introduction check procedures,
including isolating purchased animals for a period before allowing them in contact with
the rest of the herd.  For this study, it was assumed that farmers in an open farm either
conduct no introduction checks or check records for either leukosis or vaccination history
depending on the disease of concern.
Finally, both open and closed farms can vaccinate.  An adequate vaccination
program is defined as one in which cows were vaccinated for respiratory diseases
including BVD in 1997, the animals received a booster in the first year of vaccinating
(for killed BVD vaccines, this was not required if a live-virus vaccine was used), and the
vaccination and booster were given after 6 months of age to prevent interference of
maternal antibodies with the vaccine.  Vaccination is performed on all cows in the herd.
Combining these alternative practices formed 10 potential control strategies for
evaluation, as indicated in Figure 3.  The proportion of surveyed farms using each
strategy is also listed in Figure 3.  The most common control strategy involved
purchasing from other producers with vaccination and without introduction checks
(strategy 5) and raising replacements with vaccination (strategy 1).  Approximately 17%
of the surveyed farms used these strategies.15
Figure 3
Costs of Control Strategies
The first step in the analysis was to determine the costs associated with each of
the 10 control strategies (A in Figure 2).  As discussed above, the control strategies
consisted of various combinations of three general sets of practices: animal movement,
introduction checks, and vaccination.
According to the original survey (VanLeeuwen et al. 2001), the vaccines
commonly used in Maritimes were Cattlemaster 4 ($3.08 per dose), Cattlemaster 4+L5
($4.05), Sentry 4/Somnugen ($3.69), Sentry 9/Somnugen ($4.22), Triangle 4 ($3.32), and
Triangle 9 ($3.75).  An adequate vaccination program was assumed to include: 1) using
vaccine for respiratory disease including BVD in 1997; 2) the animals received a booster
in the first year of vaccination; and 3) the vaccination and booster were given after 6
months of age.  A cost for these practices of $14.04 per cow and per year was calculated
by multiplying the average price of the above vaccines ($3.68) plus the extra labor fee for
vaccination ($1.00), by the number of doses per year [1.5 = young stock (2) + mature
animal (1)], and then doubling this to take into account that any given farm has
approximately twice as many cattle on the farm (including young stock) as the number of
cows in the ADLIC records.
Three practices related to animal movement were defined: 1) raising all
replacements internally and no outside purchase, 2) purchasing directly from other
producers, and 3) purchasing from any sources.  Each farm is assumed to be categorized
into one of these independent and mutually exclusive classifications.  Raising all
replacements internally is assumed to be the most expensive of the 3 practices as more16
labor and capital is required.  The cost of raising heifers over a 2-year period is estimated
to be $1,922 based on data from the Ontario Dairy Accounting Project (ODAP) 2000
survey (Lang, 2001).  The cost is similar to recent estimates in studies from
Pennsylvania, Virginia and Iowa (Lang, 2001).  It is assumed that open farms sell all their
new-born calves at $400 and purchase their bred replacements at $2,000.  Thus, the cost
of purchasing is the difference or $1,600 per animal.  In addition, the two-year costs for
raising or purchasing heifers are divided in half to put the costs on an annual basis.
It is assumed that purchasing from non-producer sources such as public auctions
is the cheapest means to acquire a replacement.  Purchasing directly from other producers
is assumed to be more expensive due to the costs for searching and bargaining.  While the
purchase price of the animal is not likely to be different between the two sources, the
time involved in finding suitable replacements from other producers is assumed to
increase the cost by $100 per animal.  The current study assumes that 25% of the 50 cow
herd is replaced in any year so that the above per cow opportunity cost of replacement is
multiplied by 12.5.
If an animal is purchased, it may go through two possible introduction checks.
First, the animal may be placed directly into the herd at no cost but it may increase the
likelihood of increased prevalence of infection with disease.  Second, the farmer may
check the records of the cow before it enters the herd.  It is assumed that the farmer
checks for EBL at a cost of $6.50 per head and checks the vaccination history at a cost of
$5 per head in the case of the other three diseases.  These prices were from the Nebraska
Veterinary Diagnostic Laboratory System.  The annual cost for an average herd
associated with the 10 control strategies is listed in Table 117
Table 1
Relationship between Control and Disease Level
A necessary element in determining the optimal strategy is the relationship
between the management strategies and the prevalence of disease infection (also known
as the control function in the conceptual model).  The control function for each disease
was estimated using the dependent variable as infection prevalence level within a herd
and the explanatory variables as the set of management practices making up the potential
control strategies.  Because the dependent variable is bounded between 0 and 1, a Tobit
model was estimated.
Ex Post Costs of Disease
The control function described in the previous section determined the disease
level associated with each control strategy.  The next step is to assess the costs associated
with that prevalence of infection (or the damage function from the conceptual model).
Direct production loss and treatment cost of infectious diseases were assessed using a
partial budget model developed by (authors) from a framework suggested by Bennett et
al. (1999).  The structure for this model consisted of three main sections.  The first
contained information on dairy farm characteristics such as the size of the population at
risk, the prevalence of disease infection, and prices for milk and cattle.  The second
calculated the direct losses of the diseases, which are associated with milk loss,
premature voluntary culling and reduced slaughter value, mortality loss, and abortion and18
reproductive loss.  The third section estimated the costs of undertaken treatment
measures.  The components of each section are described in more detail in (authors).
Each infectious disease under study can have two states: subclinical infection
(where an animal is infected but shows no obvious physical signs of disease, although
production or other functions may be inhibited) and clinical infection (where an animal is
infected and shows physical signs of disease, such as production losses, coughing,
diarrhea, etc.).  The ex post effects of each disease include both states of infection.
RESULTS
Control Function
The results of the Tobit regression for each of the four diseases are listed in Table
2.  The signs on the explanatory variables were generally biologically plausible but
relatively few are significant at p<0.1 due to only 90 herds being in the study.  Purchasing
animals, as opposed to raising them internally, was generally associated with higher
prevalence levels for all four diseases  but the impacts were statistically insignificant
except in the case of JD.  In addition, purchasing animals through a dealer or an auction
was associated with higher prevalence levels of infection for BVD, EBL, and neosporosis
than directly buying from other producers.  Checking for leukosis in the case of EBL and
the animal’s vaccination history for the other three diseases were related to lower
prevalence of infection with all of the four diseases, albeit statistically insignificant.
These introduction checks are meant to prevent the introduction of clinically infected
animals that show symptoms of the diseases although they do not help to detect
subclinically infected animals for any of the diseases.  Checking for leukosis status is19
very important for controlling the prevalence of leukosis because prevalence can easily
rise if purchases are made without checking.
Vaccination was associated with reduced prevalence of infection for BVD, EBL,
and JD but the effect was significant only for BVD.  Because killed virus vaccines
commonly used in the surveyed area can effectively reduce the occurrence of BVD, using
vaccination was expected to show a strong negative relationship with the prevalence of
BVD.  For EBL, because BLV is primarily horizontally transmitted by blood (virus-
infected lymphocytes), vaccination is likely a surrogate measure of good management
where needles are not reused, thereby reducing other sources of blood transfer.  Details of
these results can be found in (authors).
Table 2
The full models of the regression results were used to predict the prevalence of
the four diseases associated with the 10 control strategies.  For example, for a farm that
does not purchase replacements and does not have direct contact with other cattle and
vaccinates, the prevalence level of EBL was 0.046 (=0.154+0.037*0–0.015*0+0.092*0–
0.041*0–0.108*1).  The predictions were forced to be bounded between 0 and 1.  For
example, the same control strategy for BVD resulted in a predicted prevalence of –0.265
(=0.188–0.453) but this value was truncated at 0.
Strategies using vaccination practices (1, 3, 5, 7, and 9) minimized prevalence of
infection with BVD to zero.  Because vaccination for BVD significantly protected for the
disease, herds using vaccination had lower prevalence than similar herds without
vaccination.  Average BVD prevalence of vaccinated herds was 0 while average BVD
prevalence of unvaccinated herds was 0.20.  Introduction checks were associated with20
lower prevalence of infection with BVD, compared with the same farms without
introduction checks.
For EBL, herds purchasing from other producers who check for leukosis and who
vaccinate (strategy 3) had the lowest prevalence (0.03) of infection with EBL.  Similar to
BVD, vaccination was associated with reduced prevalence of infection with the disease.
Average prevalence of EBL for vaccinated herds was 0.09 while average prevalence of
unvaccinated herds was 0.20.
All control strategies had zero prevalence of infection with JD.  For neosporosis,
farmers who purchased from other farmers and who have introduction checks of
purchased animals (strategy 4) had the lowest prevalence (0.03).
Overall, herds that conduct introduction checks on purchased animals and that
vaccinate (strategy 3) had the minimum predicted prevalence with the four diseases
(BVD and JD: 0; EBL: 0.03; neosporosis: 0.04).  The predicted prevalence associated
with the 10 strategies showed that closed farms had generally higher EBL and
neosporosis infection than farms that purchase directly from other producers.  Because
farms that were closed at the time of the study may not have been closed for long, the
farms could have already acquired substantial infection levels that were being sustained
within the herd through horizontal and vertical transmission.  This is quite possible, given
that the diseases have a subclinical state that requires laboratory testing for detection.
Table 321
Costs of Control Strategies
Given the results of the control functions of the 10 control strategies (Table 3),
economic costs derived from the strategies were measured in a spreadsheet model.  The
spreadsheet model allowed us to identify ex ante ( P V V P
P ) and ex post
[) Q Q ( P
i
O Q − + T V V P
T ] costs of the strategies.  The total costs for each of the strategies
for BVD, EBL, JD and neosporosis are discussed below.
Table 4
Costs of BVD
The spreadsheet model provided the optimal control strategy minimizing total
costs of BVD among the proposed strategies.  Five strategies (strategy 1, 3, 5, 7, and 9)
minimized the prevalence of infection with BVD at zero and consequently had no direct
loss and treatment cost.  Farms purchasing replacements from a dealer or an auction and
who vaccinated (strategy 9) were found to be the optimal control strategy because they
had the minimum total cost [$702 =  P V V P
P  ($702) + ) Q Q ( P
i
O Q − ($0) + T V V P
T ($0)].  If
the same open farms did not vaccinate (strategy 10), direct loss  [) Q Q ( P
i
O Q − ] and
treatment cost ( T V V P
T ) increased by $1,480 and $38, respectively.  The increase in ex
post costs of $1,518 is greater than the cost of vaccination ($702), showing the cost-
effectiveness of vaccinating.  For closed farms, average total disease cost was $1,283
higher than with open farms due largely to high internal replacement costs.  Similar to
open farms, vaccination on the closed farms was efficient because total costs were, on
average, $19 lower ($2,715 vs. $2,734).22
Costs of EBL
Open farms that purchased replacements through a dealer or auction without an
introduction check but who vaccinated (strategy 10) had the minimum total cost ($729),
derived mainly from no ex ante cost ( P V V P
P = $0).  Although herds purchasing from other
producers and who checked records before introduction and who vaccinated (strategy 3),
had the lowest prevalence (0.03) of disease infection and consequently the minimum ex
post cost ($78), it did not minimize the total cost because of the high costs of prevention
control ($2,174).
Although vaccination is effective in reducing the prevalence of EBL, the total
costs of EBL are higher with strategies that vaccinate than those who do not.  Average
total cost of open farms that vaccinate was $1,666 while it was $1,244 for those open
farms that do not vaccinate.  For closed farms, use of vaccination increased total costs
from $2,403 to $2,845.  The result is attributable to the relatively small production losses
associated with EBL (see authors).
Costs of JD
Since the predicted prevalence of infection with JD was zero for the 10 control
strategies, the optimal practice is the one that minimizes ex ante prevention costs.  Thus,
the optimal practice was to purchase replacements from dealers or auctions and introduce
them into the herd without any introduction checks.  Neither is vaccination used.
Costs of neosporosis
Open farms that conduct an introduction check on replacements purchased
through a dealer or an auction but not vaccinate (strategy 8) had the minimum total cost
($1,008) among strategies to control for neosporosis.  This strategy had an ex ante cost of23
$144 and ex post costs of $864.  Farms with the same set of practices except for
purchasing directly from other producers (strategy 4) had a lower prevalence of
neosporosis (0.03 vs. 0.09) but had higher ex ante costs and consequently higher total
costs ($1,682 vs. $1,008).  Neosporosis was the only one of the four diseases for which
there was not a negative relationship between vaccination and prevalence of disease
infection.  As a result, total costs for neosporosis were higher on farms that vaccinated
than those that did not.
Aggregate costs of the control strategies
The ex ante prevention costs are only incurred once for four diseases.  The ten
control strategies are used to control a number of diseases jointly.  The cost effectiveness
of a strategy in controlling all the four diseases cannot be found by simply assuming the
disease costs for each of the four diseases in Table 4.  Thus, the aggregate prevention
costs for each strategy are found by summing the ex post costs of direct production losses
and treatment expenses for each disease and adding this to the ex ante prevention cost of
the control strategy given in Table 1.
The strategy with the lowest aggregate cost did not minimize the disease costs for
any of the four diseases separately. Open farms purchasing directly from other producers,
that check records before introduction, and that do not vaccinate (strategy 4) had the
minimum aggregate total cost for the four diseases. The herd-level total cost of this
optimal control strategy was $2,122, derived from an ex ante cost of $1,394 and ex post
costs of $728  (BVD:$76, EBL:$364, JD:$0, and neosporosis:$288).  This strategy has
one of the lowest control costs but is also effective in preventing disease infection,24
particularly for neosporosis for which the predicted prevalence level was the minimum
(0.03).
Farms purchasing replacements from a dealer or an auction, conducting checks
before introducing these animals, and using vaccination (strategies 7) had the next lowest
aggregate cost.  Thus, careful purchasing of new animals is an effective means of
preventing production limiting diseases in general.
Closed farms (strategies 1 and 2) had aggregate costs more than double the cost of
the optimal strategy.  While predicted prevalence levels are generally low across the four
diseases, the reduction in direct losses does not offset the substantially higher prevention
costs associated with maintaining a closed farm.
DISCUSSION
This paper has presented a theoretical model on the economics of infectious
disease control in dairy herds and developed an empirical model to determine the optimal
set of control strategies for four production limiting diseases: BVD, EBL, JD, and
neosporosis.  The ex ante costs of implementing 10 prevention strategies were estimated
for a representative Maritime dairy farm.  The ex post costs associated with each of the
10 strategies were assessed for each disease on the basis of predicted prevalence levels
(control function) and estimated direct production losses (damage function).  The optimal
control strategy minimizing the total disease costs which are the sum of ex ante and ex
post costs.
The results in the optimal control strategies  emphasize the importance of
considering prevention cost when determining cost-effective control strategy.25
Minimizing direct production losses will not generally minimize the total costs of a given
disease.  For example, the lowest predicted prevalence of infection levels was associated
with closed farms.  However, the cost of raising all replacements internally and
preventing contact with other animals is costly.  In contrast, conducting checks on new
animals before introducing them into the herd, and vaccinating are cost-effective
strategies, particularly when considering a management strategy to minimize total costs
across all the four diseases.  The optimal strategy for dealing with an individual disease
does vary between diseases depending on its characteristics.  For example, the direct
losses with EBL were estimated to be relatively small for a given prevalence level so
minimizing prevention costs is a guiding criterion.  The same result holds for JD as there
is little difference in predicted infection rates across the investigated control strategies
because hygienic calf rearing appears to be a crucial component of disease control.
For aggregate costs of the four diseases, closed farms had the highest costs due to
assumption that open farms do not raise any heifers and that it is cheaper to buy than to
raise heifers.  This simplification pertains to only a minor portion of the dairy industry
and not the majority of farms that raise most and buy a few numbers of heifers.
Previous studies on the economics of animal disease have been limited due in part
to the large economic and epidemiological requirements (Dijkhuizen et al. 1995).  The
farm survey data on Maritime dairy farms along with disease parameters collected from
previous studies allowed the empirical model to be estimated.  However, it is important to
note that a strong assumption has been made about the direction of causation between the
practices and prevalence of disease infection.  The cross-sectional data from the Maritime
study limit the inferences only to those related to associations, not causation.  This study26
assumes that practices determine disease prevalence but time series-cross sectional data is
necessary to understand the dynamic effects of the practices.  However, the existing data
were the best available and results in reasonable predicted prevalence levels, which are
listed by control strategy in Table 3.  Future work should consider the dynamic effects of
strategies on prevalence of infection and alternative strategies such as calf-raising
practices that may be effective in controlling JD.27
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Table 1. Control costs (E) for each control strategy ($/herd/year)
Control Strategies Predicted cost
# Farm Vaccination Source Checks Calculation of Control Costs
1 Closed Yes N/A N/A ($1,922-$1,600)*0.5*0.25*50 cows +
$14.04*50cows
= $2,715
2 Closed No N/A N/A ($1,922-$1,600)*0.5*0.25*50 cows
= $2,013
3 Open Yes Other
producer
Yes ($100 + $6.5 + $5)*0.25*50 cows +
$14.04*50cows
= $2,096
4O p e nN o O t h e r
producer
Yes ($100 + $6.5 + $5)*0.25*50 cows
= $1,394
5 Open Yes Other
producer
No $100*0.25*50 cows + $14.04*50cows
= $1,952




7 Open Yes Dealer/
Auction
Yes ($6.5 + $5)*0.25*50 cows +
$14.04*50cows
= $846
8 Open No Dealer/
Auction
Yes ($6.5 + $5)*0.25*50 cows
= $144




10 Open No Dealer/
Auction
No = $030
Table 2. Tobit results on relationship between management practices and prevalence of
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  Log likelihood -69.867 -41.200 18.070 -15.308
  Psuedo R
2 0.077 0.054 -0.137 0.133
The values of the management practices represent coefficients.
( ): t-values given in parentheses.
*: Statistically significant values (p≤0.1).31
Table 3. Predicted prevalence of infection with the diseases for control strategy
Control Strategies Disease
# Farm Vaccination Source Checks BVD EBL JD neosporosis
1 Closed Yes N/A N/A 0 0.05 0 0.20
2 Closed No N/A N/A 0.19 0.15 0 0.18
3 Open Yes Other
producer
Yes 0 0.03 0 0.04
4O p e nN o O t h e r
producer
Yes 0.02 0.14 0 0.03
5 Open Yes Other
producer
No 0 0.07 0 0.14
6O p e nN o O t h e r
producer
No 0.13 0.18 0 0.12
7 Open Yes Dealer/
Auction
Yes 0 0.13 0 0.11
8 Open No Dealer/
Auction
Yes 0.28 0.24 0 0.09
9 Open Yes Dealer/
Auction
No 0 0.18 0 0.20
10 Open No Dealer/
Auction
No 0.40 0.28 0 0.1832
Table 4. Costs of production limiting disease by control strategy ($/herd)
Control Strategies Disease
# Farm Vaccination Source Checks BVD EBL JD neosporosis Aggregate
cost**
1 Closed Yes N/A N/A 2,715 2,845 2,715 4,636 4,766
2 Closed No N/A N/A 2,734 2,403 2,013 3,742 4,853
3 Open Yes Other
producer
Yes 2,096 2,174 2,096 2,480 2,558
4O p e nN o O t h e r
producer
Yes 1,470 1,758 1,394 1,682   2,122*
5 Open Yes Other
producer
No 1,952 2,134 1,952 3,297 3,479
6O p e nN o O t h e r
producer
No 1,744 1,719 1,250 2,402 3,365
7 Open Yes Dealer/
Auction
Yes 846 1,184 846 1,902 2,241
8 Open No Dealer/
Auction
Yes 1,207 769 144   1,008* 2,696
9 Open Yes Dealer/
Auction
No   702* 1,171 702 2,623 3,091
10 Open No Dealer/
Auction
No 1,518  729*   0* 1,729 3,976
  *: The optimal control strategies having the minimum costs.
**: Aggregate costs of a strategy are the ex ante prevention costs (see Table 1) plus the
      sum of the direct losses and treatment costs for each of the four diseases.33
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Figure 1. Resource adjustments and costs of dairy disease.
   (Source: adapted from McInerney, 1996)
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    Figure 2. Disease ex ante cost counteract ex post losses.
                   (Source: adopted from McInerney, 1996)
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Figure 3. Definition of management control practices
Practices
Opportunity for direct contact
                                                                  No                                                          Yes
Source of purchased animals
Introduction Checks
Vaccination
2                Yes            No       Yes              No            Yes                No       Yes                No              Yes              No
Control strategy            1               2          3                  4               5                    6           7                    8                 9                 10        
Number
Proportion of farms    0.17          0.13     0.10             0.03           0.17               0.13        0                   0              0.13             0.13
1: Introduction checks include checking for leukosis (Qleuksis) and/or vaccination history (Qvachist)
2: Vaccination includes adequate vaccination program (AVP)
Closed Farm
Purchase from other producer Purchase from dealer/auction
Yes No Yes No36